Max India Ltd(Merged)
Max India is primarily engaged in making business investment in its subsidiaries and providing management advisory services to the group companies.(Source : 201903 Annual Report Page No: 158)
- Market Cap ₹ 2,029 Cr.
- Current Price ₹ 63.6
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 64.0
- Dividend Yield 0.00 %
- ROCE -0.97 %
- ROE -1.06 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Stock is trading at 1.00 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.30% over last 3 years.
- Company has high debtors of 208 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
|---|---|---|---|---|---|
| 68 | 52 | 66 | 56 | 46 | |
| 45 | 50 | 53 | 72 | 73 | |
| Operating Profit | 23 | 1 | 13 | -16 | -27 |
| OPM % | 34% | 3% | 19% | -28% | -59% |
| -0 | 0 | -0 | -0 | -112 | |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 23 | 1 | 12 | -17 | -142 |
| Tax % | 37% | 569% | 52% | 9% | |
| 14 | -3 | 6 | -18 | -144 | |
| EPS in Rs | 478.00 | -0.10 | 0.21 | -0.69 | -5.37 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -6% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -2286% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 0% |
| Last Year: | -1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|
| Equity Capital | 0.05 | 53 | 54 | 54 |
| Reserves | 1,639 | 1,584 | 1,692 | 1,675 |
| 0 | 0 | 0 | 0 | |
| 9 | 8 | 12 | 31 | |
| Total Liabilities | 1,649 | 1,646 | 1,758 | 1,761 |
| 3 | 3 | 3 | 3 | |
| CWIP | 0 | 0 | 1 | 0 |
| Investments | 1,508 | 1,493 | 1,646 | 1,118 |
| 138 | 150 | 108 | 639 | |
| Total Assets | 1,649 | 1,646 | 1,758 | 1,761 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|
| Net Cash Flow | ||||
| Free Cash Flow | ||||
| CFO/OP |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|
| Debtor Days | 49 | 81 | 83 | 208 |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 49 | 81 | 83 | 208 |
| Working Capital Days | 58 | 59 | 90 | 79 |
| ROCE % | 0% | 1% | -1% |
Insights
In beta| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ALOS (Average Length of Stay) Days |
|
|||||||||
| ARPOB (Average Revenue Per Occupied Bed Day) INR |
||||||||||
| Average Inpatient Occupancy % |
||||||||||
| Number of Hospitals Number |
||||||||||
| Operational Beds (MHC Network) Number |
||||||||||
| OPD Footfalls Million |
||||||||||
| Antara Dehradun Cumulative Sales Units |
||||||||||
Documents
Announcements
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 11 Nov 2020
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 3 Oct 2020
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 1 Oct 2020
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 29 Sep 2020
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 29 Sep 2020
Annual reports
Concalls
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Aug 2018TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018Transcript PPT
-
Nov 2017TranscriptAI SummaryPPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptPPT
-
Feb 2017TranscriptPPT
-
Nov 2016TranscriptPPT